Please login to the form below

Not currently logged in
Email:
Password:

Red Door boosts digital team

Damien Bonafont joins from LBi
Red Door_Damien-Bonafont-and-Esha-Kharbanda

Red Door Communications has appointed Damien Bonafont as digital health specialist.

Bonafont (pictured left) joins the consultancy as a senior account director from LBi, where he was a digital health strategist. He will report to Red Door's head of digital, Matt Lowe.  

Bonafont has a masters in communication, advertising and media from the Universities of Lausanne and Barcelona, and has held a variety of roles within communications, working for clients such as AbbVie, AstraZeneca and Merck Serono. 

With experience in online word of mouth, communities and new media, Bonafont is an advocate of long-term digital planning and has launched a number of digital platforms within the field of health communications. 

Also new to Red Door is account manager Esha Kharbanda (pictured right). She joins from Gilead Sciences where she was a government affairs associate. Kharbanda has also been a policy adviser in the European Parliament, advising an MEP on EU healthcare legislation and political communications. 

“We are delighted to have two new team members with quite diverse backgrounds – they bring real skills in very specific areas,” said Red Door managing director Catherine Devaney.

“Damien's digital expertise will support our ever-growing digital offering while Esha brings with her first-hand experience of Brussels and UK Parliamentary affairs.”

24th April 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics